• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核发作后肺癌的发生:系统评价和荟萃分析。

Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis.

机构信息

Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru

Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.

出版信息

Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0025-2022. Print 2022 Sep 30.

DOI:10.1183/16000617.0025-2022
PMID:35896272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9724897/
Abstract

INTRODUCTION

People with tuberculosis experience long-term health effects beyond cure, including chronic respiratory diseases. We investigated whether tuberculosis is a risk factor for subsequent lung cancer.

METHODS

We searched PubMed, Scopus, Cochrane, Latin American and Caribbean Health Sciences Literature and the Scientific Electronic Library Online for cohort and case-control studies providing effect estimates for the association between tuberculosis and subsequent lung cancer. We pooled estimates through random-effects meta-analysis. The study was registered in PROSPERO (CDR42020178362).

RESULTS

Out of 6240 records, we included 29 cohort and 44 case-control studies. Pooled estimates adjusted for age and smoking (assessed quantitatively) were hazard ratio (HR) 1.51 (95% CI 1.30-1.76, I=81%; five studies) and OR 1.74 (95% CI 1.42-2.13, I=59%; 19 studies). The occurrence of lung cancer was increased for 2 years after tuberculosis diagnosis (HR 5.01, 95% CI 3.64-6.89; two studies), but decreased thereafter. Most studies were retrospective, had moderate to high risk of bias, and did not control for passive smoking, environmental exposure and socioeconomic status. Heterogeneity was high.

CONCLUSION

We document an association between tuberculosis and lung cancer occurrence, particularly in, but not limited to, the first 2 years after tuberculosis diagnosis. Some cancer cases may have been present at the time of tuberculosis diagnosis and therefore causality cannot be ascertained. Prospective studies controlling for key confounding factors are needed to identify which tuberculosis patients are at the highest risk, as well as cost-effective approaches to mitigate such risk.

摘要

简介

结核病患者在治愈后会长期受到健康影响,包括慢性呼吸道疾病。我们研究了结核病是否是随后发生肺癌的一个危险因素。

方法

我们在 PubMed、Scopus、Cochrane、拉丁美洲和加勒比健康科学文献以及科学电子图书馆在线检索了队列研究和病例对照研究,这些研究提供了结核病与随后发生肺癌之间关联的效应估计值。我们通过随机效应荟萃分析对估计值进行了汇总。该研究已在 PROSPERO(CDR42020178362)中注册。

结果

在 6240 条记录中,我们纳入了 29 项队列研究和 44 项病例对照研究。经过年龄和吸烟(定量评估)调整后的合并估计值为危险比(HR)1.51(95%CI 1.30-1.76,I=81%;五项研究)和比值比(OR)1.74(95%CI 1.42-2.13,I=59%;19 项研究)。在结核病诊断后 2 年内,肺癌的发生风险增加(HR 5.01,95%CI 3.64-6.89;两项研究),但此后风险降低。大多数研究为回顾性研究,存在中度至高度偏倚风险,且未控制被动吸烟、环境暴露和社会经济地位等因素。异质性很高。

结论

我们记录了结核病与肺癌发生之间的关联,特别是在结核病诊断后的 2 年内,但不仅限于此。一些癌症病例可能在结核病诊断时就已经存在,因此无法确定因果关系。需要进行前瞻性研究,控制关键混杂因素,以确定哪些结核病患者风险最高,并找到降低这种风险的具有成本效益的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/164005d96b25/ERR-0025-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/a6ee2d6a584a/ERR-0025-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/575a1ce2339d/ERR-0025-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/164005d96b25/ERR-0025-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/a6ee2d6a584a/ERR-0025-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/575a1ce2339d/ERR-0025-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9db/9724897/164005d96b25/ERR-0025-2022.03.jpg

相似文献

1
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis.肺结核发作后肺癌的发生:系统评价和荟萃分析。
Eur Respir Rev. 2022 Jul 27;31(165). doi: 10.1183/16000617.0025-2022. Print 2022 Sep 30.
2
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
5
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
6
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
9
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
10
Strategies to improve smoking cessation rates in primary care.提高初级保健中戒烟率的策略。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.

引用本文的文献

1
Methylation detection in percutaneous lung biopsy preservation fluid: a new strategy to improve lung cancer diagnosis.经皮肺活检保存液中的甲基化检测:一种改善肺癌诊断的新策略。
Front Oncol. 2025 Jul 24;15:1611244. doi: 10.3389/fonc.2025.1611244. eCollection 2025.
2
Establishment and validation of a convenient and efficient screening tool for active pulmonary tuberculosis in lung cancer patients based on common parameters.基于常见参数建立并验证一种用于肺癌患者活动性肺结核的便捷高效筛查工具。
Ther Adv Med Oncol. 2025 Jul 24;17:17588359251355058. doi: 10.1177/17588359251355058. eCollection 2025.
3
Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review.

本文引用的文献

1
Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database.利用全国代表性数据库构建的韩国个体5年肺癌风险预测模型。
Cancers (Basel). 2021 Jul 13;13(14):3496. doi: 10.3390/cancers13143496.
2
Cancer risk in tuberculosis patients in a high endemic area.高发地区结核病人的癌症风险。
BMC Cancer. 2021 Jun 9;21(1):679. doi: 10.1186/s12885-021-08391-6.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
肺癌合并肺结核的研究进展:一项叙述性综述
Transl Lung Cancer Res. 2025 Jun 30;14(6):2272-2280. doi: 10.21037/tlcr-2025-450. Epub 2025 Jun 24.
4
Low expression of miR-7-5p promotes resistance to radiotherapy in lung cancer through direct upregulation of PKP2 expression.miR-7-5p的低表达通过直接上调PKP2的表达促进肺癌对放疗的抗性。
Sci Rep. 2025 May 15;15(1):16847. doi: 10.1038/s41598-025-01001-6.
5
Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management.肺癌与肺结核并存:从发病率到治疗的全面综述
Cancer Rep (Hoboken). 2025 May;8(5):e70213. doi: 10.1002/cnr2.70213.
6
Where lung cancer and tuberculosis intersect: recent advances.肺癌与结核病的交叉领域:最新进展
Front Immunol. 2025 Apr 2;16:1561719. doi: 10.3389/fimmu.2025.1561719. eCollection 2025.
7
Clinical and imaging features of co-existent pulmonary tuberculosis and lung cancer: a population-based matching study in China.肺结核与肺癌并存的临床及影像学特征:一项基于中国人群的匹配研究
BMC Cancer. 2025 Jan 15;25(1):89. doi: 10.1186/s12885-024-13350-y.
8
Risk of TB disease in individuals with cancer.癌症患者患结核病的风险。
IJTLD Open. 2025 Jan 1;2(1):45-52. doi: 10.5588/ijtldopen.24.0440. eCollection 2025 Jan.
9
Risk of Lung Cancer and Risk Factors of Lung Cancer in People Infected with Tuberculosis.结核病感染者患肺癌的风险及肺癌的危险因素
J Cancer Prev. 2024 Dec 30;29(4):157-164. doi: 10.15430/JCP.24.016.
10
Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.免疫检查点抑制剂 (ICIs) 治疗对非小细胞肺癌 (NSCLC) 患者干扰素-γ 释放试验 (IGRA) 及诊断价值的影响。
BMC Pulm Med. 2024 Apr 12;24(1):174. doi: 10.1186/s12890-024-02980-4.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Effects of age on the association between pulmonary tuberculosis and lung cancer in a South Korean cohort.年龄对韩国队列中肺结核与肺癌关联的影响。
J Thorac Dis. 2020 Mar;12(3):375-382. doi: 10.21037/jtd.2020.01.38.
5
Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort Study.韩国肺结核与肺癌风险升高相关:全国队列研究
J Cancer. 2020 Jan 20;11(7):1899-1906. doi: 10.7150/jca.37022. eCollection 2020.
6
Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis.结核病治疗患者的长期全因死亡率:系统评价和荟萃分析。
Lancet Infect Dis. 2019 Oct;19(10):1129-1137. doi: 10.1016/S1473-3099(19)30309-3. Epub 2019 Jul 16.
7
Factors for the Early Revision of Misdiagnosed Tuberculosis to Lung Cancer: A Multicenter Study in A Tuberculosis-Prevalent Area.误诊为肺结核的患者早期被修正诊断为肺癌的相关因素:一项在结核病高发地区开展的多中心研究
J Clin Med. 2019 May 17;8(5):700. doi: 10.3390/jcm8050700.
8
Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.贝宁科托努治愈肺结核患者的肺功能损害患病率。
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):195-202. doi: 10.5588/ijtld.18.0234.
9
A guide to systematic review and meta-analysis of prognostic factor studies.预后因素研究的系统评价与Meta分析指南
BMJ. 2019 Jan 30;364:k4597. doi: 10.1136/bmj.k4597.
10
International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review.关于肺结核后慢性肺部疾病的国际研究与指南:一项系统的范围综述
BMJ Glob Health. 2018 Jul 23;3(4):e000745. doi: 10.1136/bmjgh-2018-000745. eCollection 2018.